BioCentury | Apr 7, 2014
Finance

2Q14 Financial Markets Preview: Minor adjustment

...seem to forget about losses quickly, but European investors still talk about British Biotech and Oxford GlycoSciences...
BioCentury | Apr 15, 2013
Company News

Oxford GlycoSciences Ltd. board of directors update

Oxford GlycoSciences Ltd. , Abingdon, U.K. Business: Drug discovery Appointed: James Noble, as a non-executive director; formerly finance director, British Biotech plc (BBIOY) WIR Staff...
BioCentury | Dec 24, 2007
Strategy

Platform collecting

...Abingdon, U.K.) was founded in 2003 when CEO Christian Rohlff and colleagues acquired assets from Oxford GlycoSciences plc...
BioCentury | Jun 4, 2007
Strategy

Rearview mirror

...was already listed. Prior to the proposed IPO, IDM had offered to acquire antibody company Oxford Glycosciences plc...
BioCentury | Oct 23, 2006
Strategy

Oxford Genome: Proteomics to products

...to develop products Christian Rohlff, founder and CEO, was director of proteome research collaborations at Oxford GlycoSciences plc...
...now part of UCB Group (Euronext:UCB, Brussels, Belgium). Rohlff and other colleagues acquired assets from Oxford GlycoSciences...
BioCentury | Jun 26, 2006
Finance

Actelion chronicles

...PAH E. 7/26/02 - ATLN gets European marketing rights to Zavesca for Gaucher's disease from Oxford GlycoSciences...
BioCentury | Jun 26, 2006
Finance

What Actelion's investors want

...ATLN has acquired only one product and one company: it bought Zavesca in 2002 from Oxford GlycoSciences plc...
BioCentury | May 22, 2006
Strategy

CAT nipped

...see BioCentury, Dec. 6, 2004). However, CAT also lost out on a bid to acquire Oxford Glycosciences plc...
BioCentury | Dec 12, 2005
Finance

Ebb & Flow

...the firms' life science team. Previously, Parekh was an entrepreneur-in-residence at Abingworth . Parekh co-founded Oxford GlycoSciences...
BioCentury | Sep 12, 2005
Company News

Xention Discovery Ltd. board of directors update

...Discovery Ltd. , Cambridge, U.K. Business: Cardiovascular, Neurology, Endocrine Appointed: David Ebsworth, former CEO of Oxford Glycosciences plc...
Items per page:
1 - 10 of 340
BioCentury | Apr 7, 2014
Finance

2Q14 Financial Markets Preview: Minor adjustment

...seem to forget about losses quickly, but European investors still talk about British Biotech and Oxford GlycoSciences...
BioCentury | Apr 15, 2013
Company News

Oxford GlycoSciences Ltd. board of directors update

Oxford GlycoSciences Ltd. , Abingdon, U.K. Business: Drug discovery Appointed: James Noble, as a non-executive director; formerly finance director, British Biotech plc (BBIOY) WIR Staff...
BioCentury | Dec 24, 2007
Strategy

Platform collecting

...Abingdon, U.K.) was founded in 2003 when CEO Christian Rohlff and colleagues acquired assets from Oxford GlycoSciences plc...
BioCentury | Jun 4, 2007
Strategy

Rearview mirror

...was already listed. Prior to the proposed IPO, IDM had offered to acquire antibody company Oxford Glycosciences plc...
BioCentury | Oct 23, 2006
Strategy

Oxford Genome: Proteomics to products

...to develop products Christian Rohlff, founder and CEO, was director of proteome research collaborations at Oxford GlycoSciences plc...
...now part of UCB Group (Euronext:UCB, Brussels, Belgium). Rohlff and other colleagues acquired assets from Oxford GlycoSciences...
BioCentury | Jun 26, 2006
Finance

Actelion chronicles

...PAH E. 7/26/02 - ATLN gets European marketing rights to Zavesca for Gaucher's disease from Oxford GlycoSciences...
BioCentury | Jun 26, 2006
Finance

What Actelion's investors want

...ATLN has acquired only one product and one company: it bought Zavesca in 2002 from Oxford GlycoSciences plc...
BioCentury | May 22, 2006
Strategy

CAT nipped

...see BioCentury, Dec. 6, 2004). However, CAT also lost out on a bid to acquire Oxford Glycosciences plc...
BioCentury | Dec 12, 2005
Finance

Ebb & Flow

...the firms' life science team. Previously, Parekh was an entrepreneur-in-residence at Abingworth . Parekh co-founded Oxford GlycoSciences...
BioCentury | Sep 12, 2005
Company News

Xention Discovery Ltd. board of directors update

...Discovery Ltd. , Cambridge, U.K. Business: Cardiovascular, Neurology, Endocrine Appointed: David Ebsworth, former CEO of Oxford Glycosciences plc...
Items per page:
1 - 10 of 340